Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Shenzhen Sungening Biological Co. Ltd. currently has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. Prosecution is limited to 1 distinct examiner and 1 distinct art unit. The presence of 1 distinct art unit suggests that the company's biological or pharmaceutical technology is being evaluated by a single specialized group. This focused review process applies to the 1 pending office action currently active for the company.
Sudhakar Katakam is the busiest examiner for this portfolio, managing the 1 pending office action. This represents the full count of 1 pending office action for the company. Since Sudhakar Katakam is the only one of the 1 distinct examiners involved, this individual has sole oversight of the current pending matter. The 1 busiest examiner pending action assigned to this examiner constitutes the entire active workload for the entity.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KATAKAM, SUDHAKAR | 1 | 74.8% | +23.3% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18399726 | ECHINOCANDIN-BASED DRUG, AND PREPARATION METHOD THEREFOR AND USE THEREOF | KATAKAM, SUDHAKAR | — |
| Art Unit | Apps |
|---|---|
| 1658 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18399726 | ECHINOCANDIN-BASED DRUG, AND PREPARATION METHOD THEREFOR AND USE THEREOF | KATAKAM, SUDHAKAR | 1658 | §103 | Non-Final OA | — | Pending | Dec 29, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialShenzhen Sungening Biological Co. Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Sudhakar Katakam has the most, with 1 of Shenzhen Sungening Biological Co. Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
